Plus Therapeutics | CYTX - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Baxter International USD 6.5B 3.82B 2026-09
Cerus USD 34.78M 2.98M 2024-12
Dr.Reddys Laboratories INR 74.82B 2.93B 2026-09
Haemonetics USD 145.79M 448K 2026-09
Northwest Biotherapeutics USD 11.39M 120.04M 2026-03
Plus Therapeutics USD 8.15M 1.04M 2026-03
Sanofi EUR 10.51B 598M 2026-09
Starpharma Holdings AUD 11.7M 7.69M 2025-12
Sun Pharmaceuticals INR 122.92B 5.49B 2026-09
Teva Pharmaceutical Industries USD 3.18B 733M 2026-09